NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 41 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $838,974 | +17.9% | 1,010,812 | -0.5% | 0.00% | – |
Q1 2023 | $711,407 | +37.5% | 1,016,296 | 0.0% | 0.00% | – |
Q4 2022 | $517,295 | -21.3% | 1,016,296 | -0.9% | 0.00% | – |
Q3 2022 | $657,000 | -43.2% | 1,025,886 | -8.7% | 0.00% | – |
Q2 2022 | $1,157,000 | -51.9% | 1,123,205 | -12.3% | 0.00% | – |
Q1 2022 | $2,407,000 | -68.8% | 1,280,501 | -20.0% | 0.00% | – |
Q4 2021 | $7,712,000 | -33.8% | 1,600,003 | -0.7% | 0.00% | – |
Q3 2021 | $11,644,000 | -20.8% | 1,610,572 | +1.1% | 0.00% | – |
Q2 2021 | $14,709,000 | -21.3% | 1,593,582 | +5.0% | 0.00% | -100.0% |
Q1 2021 | $18,692,000 | +14.9% | 1,518,403 | +31.6% | 0.00% | – |
Q4 2020 | $16,265,000 | +24.5% | 1,153,490 | +5.9% | 0.00% | – |
Q3 2020 | $13,069,000 | -20.8% | 1,089,020 | +9.5% | 0.00% | -100.0% |
Q2 2020 | $16,506,000 | +175.0% | 994,339 | +88.5% | 0.00% | – |
Q1 2020 | $6,002,000 | -6.6% | 527,451 | +1.1% | 0.00% | – |
Q4 2019 | $6,429,000 | +819.7% | 521,850 | +112.6% | 0.00% | – |
Q3 2019 | $699,000 | – | 245,408 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,386,300 | $19,547,000 | 2.55% |
EcoR1 Capital, LLC | 3,122,704 | $44,030,000 | 2.37% |
Redmile Group, LLC | 4,131,869 | $58,259,000 | 0.70% |
Boxer Capital, LLC | 1,501,058 | $21,165,000 | 0.68% |
HighVista Strategies LLC | 69,727 | $983,000 | 0.63% |
Baker Brothers Advisors | 3,821,740 | $53,887,000 | 0.20% |
Highland Private Wealth Management | 93,998 | $1,326,000 | 0.12% |
Sio Capital Management, LLC | 38,312 | $540,000 | 0.11% |
Point72 Asset Management, L.P. | 1,195,725 | $16,860,000 | 0.08% |
Granahan Investment Management | 246,299 | $3,473,000 | 0.08% |